Aquestive Therapeutics Inc. has announced the promotion of Sherry Korczynski to the position of Chief Commercial Officer, effective July 22, 2025. Previously serving as Senior Vice President of Sales and Marketing, Korczynski joined the company in February 2024. She brings over two decades of experience in commercial and launch roles at various pharmaceutical companies, including leading efforts for EpiPen. In her new role, she will oversee the global commercial strategy for Anaphylm, an innovative orally delivered epinephrine product.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。